4/A//SEC Filing
Arthur David J. 4/A
Accession 0001615219-22-000155
CIK 0001615219other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:34 PM ET
Size
6.6 KB
Accession
0001615219-22-000155
Insider Transaction Report
Form 4/AAmended
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+2,693$4,670→ 13,719 total
Holdings
- 564(indirect: By son)
Common Stock
- 552(indirect: By daughter)
Common Stock
Footnotes (1)
- [F1]The Reporting Person's previous Form 4 filed on November 7, 2022 and amended on November 8, 2022 incorrectly reported the Reporting Person acquiring 10,000 shares of common stock under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c), when it should have been reported as 2,693 shares of common stock.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001769331
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:34 PM ET
- Size
- 6.6 KB